Stoke Therapeutics Inc (STOK)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
総売上 | 2.91M | 3.27M | 5.15M | -2.48M | 3.31M | 2.8M | 4.22M | 4.83M |
営業利益 | -27.15M | -27.18M | -24.69M | -33.26M | -27.23M | -29.59M | -28.37M | -29.34M |
税引前収入 | -26.11M | -25.66M | -22.55M | -30.65M | -24.54M | -26.96M | -26.37M | -25.7M |
純利益 | -26.11M | -25.66M | -22.55M | -30.65M | -24.54M | -26.96M | -26.37M | -25.7M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -27.11M | -27.13M | -24.65M | -33.22M | -27.19M | -29.55M | -28.8M | -29.39M |
EBITDA | -26.76M | -26.57M | -24.09M | -32.65M | -26.6M | -28.96M | -27.81M | -28.79M |
年末 2023年12月31日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 12.41M | 8.78M |
営業利益 | -5.55M | -12.78M | -35.68M | -53.04M | -86.07M | -104.36M | -114.77M |
税引前収入 | -5.56M | -12.52M | -32.33M | -52.24M | -85.81M | -101.07M | -104.7M |
純利益 | -5.56M | -12.52M | -32.33M | -52.24M | -85.81M | -101.07M | -104.7M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.834 | -0.054 | -0.125 | -0.199 | -0.327 | -0.381 | -0.387 |
EBIT | -5.56M | -12.79M | -35.68M | -52.99M | -85.93M | -104.19M | -114.61M |
EBITDA | -5.44M | -12.57M | -35.23M | -52.16M | -85.09M | -102.81M | -112.3M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約